Search

Your search keyword '"Enomoto, Takayuki"' showing total 505 results
Start Over Author "Enomoto, Takayuki" Database Unpaywall
505 results on '"Enomoto, Takayuki"'

1. Identification of ovarian high-grade endometrioid-type tumors through multi-omics analysis: JGOG3025-TR2 study

Author

Takamatsu, Shiro, primary, Hillman, R. Tyler, additional, Yoshihara, Kosuke, additional, Baba, Tsukasa, additional, Shimada, Muneaki, additional, Yoshida, Hiroshi, additional, Kajiyama, Hiroaki, additional, Oda, Katsutoshi, additional, Mandai, Masaki, additional, Okamoto, Aikou, additional, Enomoto, Takayuki, additional, and Matsumura, Noriomi, additional

Published
2024
Full Text
View/download PDF

2. Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1α and tumor progression of clear cell ovarian cancer

Author

Mori, Yutaro, primary, Okimoto, Yoshie, additional, Sakai, Hiroaki, additional, Kanda, Yusuke, additional, Ohata, Hirokazu, additional, Shiokawa, Daisuke, additional, Suzuki, Mikiko, additional, Yoshida, Hiroshi, additional, Ueda, Haruka, additional, Sekizuka, Tomoyuki, additional, Tamura, Ryo, additional, Yamawaki, Kaoru, additional, Ishiguro, Tatsuya, additional, Mateos, Raul Nicolas, additional, Shiraishi, Yuichi, additional, Yatabe, Yasushi, additional, Hamada, Akinobu, additional, Yoshihara, Kosuke, additional, Enomoto, Takayuki, additional, and Okamoto, Koji, additional

Published
2024
Full Text
View/download PDF

3. Supplementary Figure legend from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

4. Supplementary Table 3 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

5. Supplementary Table 7 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

6. Supplementary Table 7 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

7. Supplementary Table 8 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

8. Supplementary Table 6 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

9. Data from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

10. Supplementary Figure 2 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

11. Supplementary Figure 2 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

12. Supplementary Table 3 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

13. Supplementary Table 6 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

14. Supplementary Table 9 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

15. Supplementary Table 8 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

16. Supplementary Table 4 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

17. Supplementary Table 5 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

18. Supplementary Table 1 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

19. Supplementary Table 1 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

20. Data from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

21. Supplementary Table 4 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

22. Supplementary Table 5 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

23. Supplementary Figure 1 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

24. Supplementary Table 9 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

25. Supplementary Table 10 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

26. Supplementary Figure 1 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

27. Supplementary Table 10 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

28. Supplementary Table 2 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

29. Supplementary Table 2 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

30. Supplementary Figure legend from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, primary, Ueda, Haruka, primary, Yamaguchi, Manako, primary, Yamawaki, Kaoru, primary, Tamura, Ryo, primary, Suda, Kazuaki, primary, Ishiguro, Tatsuya, primary, Adachi, Sosuke, primary, Nagase, Yoshikazu, primary, Ueda, Yutaka, primary, Ueda, Masashi, primary, Abiko, Kaoru, primary, Kagabu, Masahiro, primary, Baba, Tsukasa, primary, Nakaoka, Hirofumi, primary, Enomoto, Takayuki, primary, Murai, Junko, primary, and Yoshihara, Kosuke, primary

Published
2024
Full Text
View/download PDF

31. Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan

Author

Machida, Hiroko, primary, Matsuo, Koji, additional, Higashi, Takahiro, additional, Aoki, Daisuke, additional, Enomoto, Takayuki, additional, Okamoto, Aikou, additional, Katabuchi, Hidetaka, additional, Nagase, Satoru, additional, Mandai, Masaki, additional, Yaegashi, Nobuo, additional, Yamagami, Wataru, additional, and Mikami, Mikio, additional

Published
2024
Full Text
View/download PDF

32. Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT)

Author

Kobayashi, Yusuke, primary, Shimada, Muneaki, additional, Tamate, Masato, additional, Cho, Hyun Woong, additional, Zhu, Jun, additional, Chou, Hung-Hsueh, additional, Kajiyama, Hiroaki, additional, Okamoto, Aikou, additional, Aoki, Daisuke, additional, Kang, Sokbom, additional, Lee, Jeong-Won, additional, Kim, Jae-Weon, additional, Kim, Jae-Hoon, additional, Lin, Zhongqiu, additional, Liu, Jihong, additional, Wu, Xiaohua, additional, Lai, Hung-Cheng, additional, Chang, Ting-Chang, additional, Lai, Chyong-Huey, additional, Kim, Yong Man, additional, and Enomoto, Takayuki, additional

Published
2024
Full Text
View/download PDF

34. PR035/#95 A cost-effectiveness analysis of hospital treatment volume and survival outcomes in patients with endometrial cancer in Japan

Author

Machida, Hiroko, primary, Mikami, Mikio, additional, Matsuo, Koji, additional, Aoki, Daisuke, additional, Enomoto, Takayuki, additional, Okamoto, Aikou, additional, Katabuchi, Hidetaka, additional, Nagase, Satoru, additional, Mandai, Masaki, additional, Yaegashi, Nobuo, additional, and Yamagami, Wataru, additional

Published
2023
Full Text
View/download PDF

36. Intentions for catch-up HPV vaccination in Japan: an internet survey

Author

Nakagawa, Satoshi, primary, Yagi, Asami, additional, Ueda, Yutaka, additional, Ikeda, Sayaka, additional, Kakuda, Mamoru, additional, Hiramatsu, Kosuke, additional, Miyoshi, Ai, additional, Kimura, Toshihiro, additional, Hirai, Kei, additional, Sekine, Masayuki, additional, Nakayama, Tomio, additional, Kobayashi, Eiji, additional, Miyagi, Etsuko, additional, Enomoto, Takayuki, additional, and Kimura, Tadashi, additional

Published
2023
Full Text
View/download PDF

37. Gestational choriocarcinoma

Author

Bogani, Giorgio, primary, Ray-Coquard, Isabelle, additional, Mutch, David, additional, Vergote, Ignace, additional, Ramirez, Pedro T, additional, Prat, Jaime, additional, Concin, Nicole, additional, Ngoi, Natalie Yan Li, additional, Coleman, Robert L, additional, Enomoto, Takayuki, additional, Takehara, Kazuhiro, additional, Denys, Hannelore, additional, Lorusso, Domenica, additional, Takano, Masashi, additional, Sagae, Satoru, additional, Wimberger, Pauline, additional, Segev, Yakir, additional, Kim, Se Ik, additional, Kim, Jae-Weon, additional, Herrera, Fernanda, additional, Mariani, Andrea, additional, Brooks, Rebecca A, additional, Tan, David, additional, Paolini, Biagio, additional, Chiappa, Valentina, additional, Longo, Mariangela, additional, Raspagliesi, Francesco, additional, Benedetti Panici, Pierluigi, additional, Di Donato, Violante, additional, Caruso, Giuseppe, additional, Colombo, Nicoletta, additional, Pignata, Sandro, additional, Zannoni, Gianfranco, additional, Scambia, Giovanni, additional, and Monk, Bradley J, additional

Published
2023
Full Text
View/download PDF

38. SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian carcinoma

Author

Akashi, Hidehiko, primary, Yachida, Nozomi, additional, Ueda, Haruka, additional, Yamaguchi, Manako, additional, Yamawaki, Kaoru, additional, Tamura, Ryo, additional, Suda, Kazuaki, additional, Ishiguro, Tatsuya, additional, Adachi, Sosuke, additional, Nagase, Yoshikazu, additional, Ueda, Yutaka, additional, Ueda, Masashi, additional, Abiko, Kaoru, additional, Kagabu, Masahiro, additional, Baba, Tsukasa, additional, Nakaoka, Hirofumi, additional, Enomoto, Takayuki, additional, Murai, Junko, additional, and Yoshihara, Kosuke, additional

Published
2023
Full Text
View/download PDF

44. Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial

Author

Nagao, Shoji, primary, Fujiwara, Keiichi, additional, Yamamoto, Kouji, additional, Tanabe, Hiroshi, additional, Okamoto, Aikou, additional, Takehara, Kazuhiro, additional, Saito, Motoaki, additional, Fujiwara, Hiroyuki, additional, Tan, David S.P., additional, Yamaguchi, Satoshi, additional, Adachi, Sosuke, additional, Kikuchi, Akira, additional, Hirasawa, Takeshi, additional, Yokoi, Takeshi, additional, Nagai, Tomonori, additional, Sato, Toyomi, additional, Kamiura, Shoji, additional, Fujishita, Akira, additional, Loong, Wong Wai, additional, Chan, Karen, additional, Syks, Peter, additional, Olawaye, Alexsander, additional, Ryu, Sang-Young, additional, Shigeta, Hiroyuki, additional, Kondo, Eiji, additional, Yokoyama, Yoshihito, additional, Matsumoto, Takashi, additional, Hasegawa, Kosei, additional, and Enomoto, Takayuki, additional

Published
2023
Full Text
View/download PDF

45. Supplementary Table S1 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

46. Data from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

47. Supplementary Figure S1 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Figure S1 from LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Author

Hiramatsu, Kosuke, primary, Serada, Satoshi, primary, Enomoto, Takayuki, primary, Takahashi, Yusuke, primary, Nakagawa, Satoshi, primary, Nojima, Satoshi, primary, Morimoto, Akiko, primary, Matsuzaki, Shinya, primary, Yokoyama, Takuhei, primary, Takahashi, Tsuyoshi, primary, Fujimoto, Minoru, primary, Takemori, Hiroshi, primary, Ueda, Yutaka, primary, Yoshino, Kiyoshi, primary, Morii, Eiichi, primary, Kimura, Tadashi, primary, and Naka, Tetsuji, primary

Published
2023
Full Text
View/download PDF

49. Data from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

50. Supplementary Table 3 from High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Author

Yoshihara, Kosuke, primary, Tsunoda, Tatsuhiko, primary, Shigemizu, Daichi, primary, Fujiwara, Hiroyuki, primary, Hatae, Masayuki, primary, Fujiwara, Hisaya, primary, Masuzaki, Hideaki, primary, Katabuchi, Hidetaka, primary, Kawakami, Yosuke, primary, Okamoto, Aikou, primary, Nogawa, Takayoshi, primary, Matsumura, Noriomi, primary, Udagawa, Yasuhiro, primary, Saito, Tsuyoshi, primary, Itamochi, Hiroaki, primary, Takano, Masashi, primary, Miyagi, Etsuko, primary, Sudo, Tamotsu, primary, Ushijima, Kimio, primary, Iwase, Haruko, primary, Seki, Hiroyuki, primary, Terao, Yasuhisa, primary, Enomoto, Takayuki, primary, Mikami, Mikio, primary, Akazawa, Kohei, primary, Tsuda, Hitoshi, primary, Moriya, Takuya, primary, Tajima, Atsushi, primary, Inoue, Ituro, primary, and Tanaka, Kenichi, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results